Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / SHS
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
8,240,474
-
Shares change
-
+8,240,474
-
Total reported value, excl. options
-
$135,720,000
-
Value change
-
+$135,720,000
-
Number of buys
-
32
-
Price
-
$16.47
Significant Holders of AC Immune SA - SHS (ACIU) as of Q3 2016
32 filings reported holding ACIU - AC Immune SA - SHS as of Q3 2016.
AC Immune SA - SHS (ACIU) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8,240,474 shares
.
Largest 10 shareholders include FMR LLC (3,208,587 shares), Duquesne Family Office LLC (1,500,000 shares), Temasek Holdings (Private) Ltd (1,337,500 shares), Hillhouse Capital Management, Ltd. (550,000 shares), PointState Capital LP (425,000 shares), Monashee Investment Management LLC (275,000 shares), Artal Group S.A. (150,000 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (100,000 shares), HIGHLAND CAPITAL MANAGEMENT LP (87,900 shares), and Alyeska Investment Group, L.P. (85,000 shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.